Insider filing · HUMA

Brady W Dougan sold $3.7M of Humacyte (HUMA)

Executed Aug 18 2025, disclosed Aug 20 2025, 2 days later.

Returns are measured on stock purchases only.

BD Brady W Dougan Director profile →

Brady W Dougan (Director) filed 2 Form 4 reports in the past 24 months (0 purchases, 2 sales), most often in Humacyte, Inc. (HUMA). The largest single filing was $6.6M of HUMA (1,500,000 sh across 3 lots, as filed), executed Nov 18 2024.

HUMA Humacyte, Inc. HUMA · Healthcare · 6 filings in 24 months ticker →

Healthcare · Humacyte, Inc., together with its subsidiaries, engages in the development and manufacture of off-the-shelf, implantable, and bioengineered…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→